Andre Ghetti

Andre Ghetti Email and Phone Number

Chief Executive Officer at AnaBios Corporation @ AnaBios Corporation
Andre Ghetti's Location
San Diego, California, United States, United States
Andre Ghetti's Contact Details

Andre Ghetti personal email

n/a

Andre Ghetti phone numbers

About Andre Ghetti

Dynamic biotechnology executive with over 20 years of experience and track record of success in biomedical research, innovation and commercialization. Consistent source of bold, innovative business strategies that provide a major boost to growth, top- and bottom-line performance, operational performance, and shareholder value.Breadth and depth of experience in several therapeutic areas including: neurological and cardiovascular diseases. Passionate about the implementation of innovative drug discovery paradigms and therapeutics addressing major unmet medical needs. Strong track record in leading, motivating and developing teams to achieve corporate objectives.Key Strengths• Vision, Strategy, Execution and Leadership• Corporate Development- Licensing & Strategic Alliances: Due Diligence, Deal Structuring & Negotiation • Innovation- Identification of Opportunities and Commercialization• R&D Planning and Management• Intellectual Property Strategy and Commercialization• Cost Analysis, Reduction & Control• Team Building

Andre Ghetti's Current Company Details
AnaBios Corporation

Anabios Corporation

View
Chief Executive Officer at AnaBios Corporation
Andre Ghetti Work Experience Details
  • Anabios Corporation
    Ceo
    Anabios Corporation Jun 2013 - Present
    San Diego, Ca, Us
    Technology platform development and commercialization - Proprietary cell- and tissue-based translational models - Contract researchPharmaceutical assets licensing - Pain - Heart diseaseStrategic alliancesDrug discovery & developmentFDA/regulatory biomarker qualificationFundraising
    View
  • Anabios Corporation
    President & Chief Scientific Officer
    Anabios Corporation 2011 - 2013
    San Diego, Ca, Us
    As the President and Chief Scientific Officer at AnaBios Corporation, led the development of a new translational research and drug discovery platform based entirely on the interrogation of human cells, tissues and organs. Dr. Ghetti and his colleagues have generated technologies that allow for the investigation of human physiology and pharmacology in ex-vivo setting. These studies (called “Phase X, ex-vivo), provide scores of human data at the pre-clinical stage and allow drug discovery programs to select clinical candidates based on relevant information. The adoption of Phase X approach is helping pharmaceutical companies that are partnering with AnaBios, drastically reduce attrition of clinical compounds due to efficacy or safety issues.Human studies in Phase X (ex-vivo) models - Pain - Neurodegenerative diseases - Neurotoxicity - Cardiovascular drug discovery - Cardiovascular drug safety - Assay development - In vitro models
    View
  • Sanford-Burnham Medical Research Institute
    Visiting Scientist
    Sanford-Burnham Medical Research Institute 2011 - 2013
    La Jolla, Ca, Us
    View
  • Aviva Biosciences
    President
    Aviva Biosciences 2008 - 2011
    San Diego, Ca, Us
    Marketing/distribution agreementsTechnology licensingDrug discovery servicesBiomarkers identification technologies R&D
    View
  • Aviva Biosciences
    Sr. Director
    Aviva Biosciences 2004 - 2007
    San Diego, Ca, Us
    Drug discovery servicesIon channel drug screeningAutomated electrophysiology technologies
    View
  • Vertex Pharmaceuticals
    Sr. Scientist
    Vertex Pharmaceuticals 2001 - 2004
    Boston, Ma, Us
    Pain drug discoveryCardiac drug safety
    View
  • Salk Institute For Biological Studies
    Staff Scientist - Molecular Neurobiology Department
    Salk Institute For Biological Studies 1996 - 2001
    La Jolla, Ca, Us
    Neuronal network functionSynaptic transmission/plasticityGlutamate receptorsRNA editingNeuron-glia functional interactionsEpilepsyDevelopment of new research tool: transgenic mouse models, fluorescent tagged fusion proteins, chimeric ion channels
    View

Andre Ghetti Skills

Drug Discovery Pharmacology Pharmaceutical Industry Biomarkers Commercialization Translational Research Electrophysiology Neuroscience R&d Technology Transfer Entrepreneurship Team Management Clinical Development Biopharmaceuticals Drug Development Fundraising Cell Biology Managing Start Ups

Andre Ghetti Education Details

  • Caltech
    Caltech
    Rna Biochemistry
  • University Of Verona (Italy)
    University Of Verona (Italy)
    Molecular And Cellular Physiology
  • University Of Pavia (Italy)
    University Of Pavia (Italy)
    Molecular Biology

Frequently Asked Questions about Andre Ghetti

What company does Andre Ghetti work for?

Andre Ghetti works for Anabios Corporation

What is Andre Ghetti's role at the current company?

Andre Ghetti's current role is Chief Executive Officer at AnaBios Corporation.

What is Andre Ghetti's email address?

Andre Ghetti's email address is gh****@****ios.com

What is Andre Ghetti's direct phone number?

Andre Ghetti's direct phone number is +185836*****

What schools did Andre Ghetti attend?

Andre Ghetti attended Caltech, University Of Verona (Italy), University Of Pavia (Italy).

What skills is Andre Ghetti known for?

Andre Ghetti has skills like Drug Discovery, Pharmacology, Pharmaceutical Industry, Biomarkers, Commercialization, Translational Research, Electrophysiology, Neuroscience, R&d, Technology Transfer, Entrepreneurship, Team Management.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.